• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

武汉、湖北省其他地区和中国其他地区 COVID-19 病死率差异的生态学研究。

Ecological Study on Differences in COVID-19 Fatality among Wuhan, Rest of Hubei, and Rest of China.

机构信息

Clinical Division, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 999077, China.

School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria 3083, Australia.

出版信息

J Epidemiol Glob Health. 2021 Mar;11(1):42-45. doi: 10.2991/jegh.k.200902.001. Epub 2020 Sep 10.

DOI:10.2991/jegh.k.200902.001
PMID:33009735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7958285/
Abstract

BACKGROUND

China's vigorous anti-COVID-19 campaign has been going on for three months since January 20, which has contained the spread of the virus across China.

OBJECTIVES

Epidemiological investigations found that COVID-19 fatality rates in Wuhan, rest parts of Hubei province except Wuhan (Rest of Hubei) and rest parts of Mainland China except Hubei province (Rest of China) were different. An ecological study was conducted to analyze the reasons and provide the world with China's anti-COVID-19 epidemic experiences.

METHODS

Infected cases from Mainland China were divided into three populations: Wuhan, Rest of Hubei and Rest of China. Methods were based on Total confirmed cases, daily severe cases, total deaths from February 12 to April 20 were collected for statistical analysis.

RESULTS

50,333 total confirmed cases in Wuhan made up the most substantial part by comparison with 17,795 in Rest of Hubei and 14,630 in Rest of China, respectively. In the early stage of the COVID-19 epidemic, daily severe cases in Wuhan accounted for the majority, and as the epidemic controlled, severe cases in all three populations decreased. Total deaths in Wuhan constituted the most significant proportion, with the highest 3869 in contrast to 643 in Rest of Hubei and 120 in Rest of China. The fatality rates in Wuhan ranged from 2.82% to 7.69%, much higher than 1.80-3.61% in Rest of Hubei, and 0.49-0.88% in Rest of China. Pearson chi-square test for fatality rates in the three populations demonstrated significant differences ( < 0.01).

CONCLUSION

The ecological comparison study among the three populations have proved that social distancing, quarantine, lockdown, cutting off sources of infection and transmission routes, early detection, early isolation, early treatment are all vital to control the epidemic by reducing COVID-19 confirmed cases, severe cases and the fatality rate.

摘要

背景

自 2020 年 1 月 20 日以来,中国开展了为期三个月的抗击新冠肺炎疫情的“战疫”,有效遏制了疫情在中国的扩散。

目的

流行病学调查发现,武汉市、湖北省武汉市以外地区(湖北省其他地区)和中国湖北省以外地区(中国其他地区)的新冠肺炎病死率存在差异。本生态研究旨在分析原因,并为世界提供中国抗击新冠肺炎疫情的经验。

方法

中国大陆的感染病例分为三个群体:武汉、湖北省其他地区和中国其他地区。方法基于 2 月 12 日至 4 月 20 日的总确诊病例数、每日重症病例数和总死亡人数进行统计分析。

结果

与湖北省其他地区的 17795 例和中国其他地区的 14630 例相比,武汉市共有 50333 例确诊病例,占比最大。在新冠肺炎疫情早期,武汉市每日重症病例数居多,随着疫情得到控制,三个地区的重症病例数均有所下降。武汉市的总死亡人数构成比例最大,为 3869 例,而湖北省其他地区和中国其他地区分别为 643 例和 120 例。武汉市病死率在 2.82%至 7.69%之间,远高于湖北省其他地区的 1.80%至 3.61%,以及中国其他地区的 0.49%至 0.88%。对三个地区病死率的 Pearson 卡方检验表明差异具有统计学意义(<0.01)。

结论

对三个地区的生态比较研究表明,通过减少新冠肺炎确诊病例、重症病例和病死率,采取社交距离、隔离、封锁、切断传染源和传播途径、早发现、早隔离、早治疗等措施对控制疫情至关重要。

相似文献

1
Ecological Study on Differences in COVID-19 Fatality among Wuhan, Rest of Hubei, and Rest of China.武汉、湖北省其他地区和中国其他地区 COVID-19 病死率差异的生态学研究。
J Epidemiol Glob Health. 2021 Mar;11(1):42-45. doi: 10.2991/jegh.k.200902.001. Epub 2020 Sep 10.
2
Transmission patterns of COVID-19 in the mainland of China and the efficacy of different control strategies: a data- and model-driven study.中国大陆 COVID-19 的传播模式及不同防控策略的效果:基于数据和模型的研究。
Infect Dis Poverty. 2020 Jul 6;9(1):83. doi: 10.1186/s40249-020-00709-z.
3
Study on SARS-CoV-2 transmission and the effects of control measures in China.中国 SARS-CoV-2 传播及防控措施效果研究。
PLoS One. 2020 Nov 30;15(11):e0242649. doi: 10.1371/journal.pone.0242649. eCollection 2020.
4
Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.中国大陆(不含湖北省) 2019 年冠状病毒病(COVID-19)传播的风险估计和预测。
Infect Dis Poverty. 2020 Aug 24;9(1):116. doi: 10.1186/s40249-020-00683-6.
5
Basic reproduction number and predicted trends of coronavirus disease 2019 epidemic in the mainland of China.基本再生数和中国大陆 2019 冠状病毒病流行趋势预测。
Infect Dis Poverty. 2020 Jul 16;9(1):94. doi: 10.1186/s40249-020-00704-4.
6
Correlation between the migration scale index and the number of new confirmed coronavirus disease 2019 cases in China.中国新型冠状病毒病新增确诊病例数与迁移规模指数的相关性。
Epidemiol Infect. 2020 May 19;148:e99. doi: 10.1017/S0950268820001119.
7
Lockdown Contained the Spread of 2019 Novel Coronavirus Disease in Huangshi City, China: Early Epidemiological Findings. lockdown 限制措施遏制了 2019 年新型冠状病毒病在中国黄石市的传播:早期流行病学调查结果。
Clin Infect Dis. 2020 Sep 12;71(6):1454-1460. doi: 10.1093/cid/ciaa390.
8
Modeling the epidemic dynamics and control of COVID-19 outbreak in China.中国新冠疫情爆发的流行动力学建模与防控
Quant Biol. 2020;8(1):11-19. doi: 10.1007/s40484-020-0199-0. Epub 2020 Mar 11.
9
[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].[中国2019新型冠状病毒病(COVID-19)疫情的流行病学特征]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003.
10
COVID-19 epidemic phases and morbidity in different areas of Chinese mainland, 2020.2020 年中国内地不同地区的 COVID-19 疫情阶段和发病情况。
Front Public Health. 2023 Apr 6;11:1151038. doi: 10.3389/fpubh.2023.1151038. eCollection 2023.

引用本文的文献

1
Manifestations and Outcomes of Intracerebral Hemorrhage During the COVID-19 Pandemic in China: Multicenter, Longitudinal Cohort Study.中国 COVID-19 大流行期间的脑出血表现和结局:多中心、纵向队列研究。
JMIR Public Health Surveill. 2023 Dec 13;9:e34386. doi: 10.2196/34386.

本文引用的文献

1
Global COVID-19: Warnings and suggestions based on experience of China.全球 COVID-19 疫情:基于中国经验的警示与建议。
J Glob Health. 2020 Jun;10(1):011005. doi: 10.7189/jogh.10.011005.
2
Novel coronavirus disease (COVID-19) outbreak: Now is the time to refresh pandemic plans.新型冠状病毒病(COVID-19)疫情:现在是时候更新大流行应对计划了。
J Bus Contin Emer Plan. 2020 Jan 1;13(4):298-312.
3
Understanding dynamics of pandemics.理解大流行病的动态。
Turk J Med Sci. 2020 Apr 21;50(SI-1):515-519. doi: 10.3906/sag-2004-133.
4
Updating the diagnostic criteria of COVID-19 "suspected case" and "confirmed case" is necessary.有必要更新新冠病毒“疑似病例”和“确诊病例”的诊断标准。
Mil Med Res. 2020 Apr 4;7(1):17. doi: 10.1186/s40779-020-00245-9.
5
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools.理解 SARS-CoV-2 介导的炎症反应:从机制到潜在的治疗工具。
Virol Sin. 2020 Jun;35(3):266-271. doi: 10.1007/s12250-020-00207-4. Epub 2020 Mar 3.
6
Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.通过隔离病例和接触者控制 COVID-19 疫情爆发的可行性。
Lancet Glob Health. 2020 Apr;8(4):e488-e496. doi: 10.1016/S2214-109X(20)30074-7. Epub 2020 Feb 28.
7
The Wuhan SARS-CoV-2-What's next for China.武汉的新冠病毒——中国的下一步是什么。
J Med Virol. 2020 Jun;92(6):546-547. doi: 10.1002/jmv.25738. Epub 2020 Mar 18.
8
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.冠状病毒病(COVID-19)疫情的流行病学和发病机制。
J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.
9
Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak.隔离、检疫、社交距离和社区管控:旧型公共卫生措施在新型冠状病毒(2019-nCoV)疫情中的关键作用。
J Travel Med. 2020 Mar 13;27(2). doi: 10.1093/jtm/taaa020.
10
What to do next to control the 2019-nCoV epidemic?接下来要采取什么措施来控制2019新型冠状病毒疫情?
Lancet. 2020 Feb 8;395(10222):391-393. doi: 10.1016/S0140-6736(20)30300-7.